PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Symptom | C0011847|diabetes |
| Sentences | 31 |
| PubMedID- 22039372 | Also, the risk of diabetes in schizophrenia is increased by use of atypical apds (lean and pajonk, 2003). |
| PubMedID- 24688610 | The only other publishedstudy comparing antihyperglycemic medication adherence between these two patientpopulations found that the prevalence of antihyperglycemic medication adherence wassignificantly greater (mpr=0.8-1.2) and antihyperglycemic medication nonadherence(mpr<0.8) was significantly lower in diabetes patients with schizophrenia thanwithout schizophrenia.12 our study did find arelationship between adherence rates for antipsychotic and antihyperglycemicmedication. |
| PubMedID- 20923919 | A community study in the usa examined how treatment of diabetes in patients with schizophrenia (n = 101) compared with that in diabetic patients with no mental illness (n = 99) (dixon et al., 2004). |
| PubMedID- 23840437 | schizophrenia with diabetes performed worse than schizophrenia without diabetes in immediate memory (p<0.01) and total rbans scores (<0.05), and showed a trend for decreased attention (p = 0.052) and visuospatial/constructional capacity (p = 0.063). |
| PubMedID- 22028998 | Similarly, a positive family history may increase the risk of developing diabetes in individuals with schizophrenia up to threefold. |
| PubMedID- 26209325 | Conclusion: elevated risk for type 2 diabetes in people with schizophrenia is not simply a consequence of antipsychotic medication; type 2 diabetes and schizophrenia share familial risk factors. |
| PubMedID- 20923916 | A community study showed better control of diabetes in patients with schizophrenia than controls (dixon et al., 2004). |
| PubMedID- 20923920 | The increased prevalence of diabetes in patients with schizophrenia in an increasingly obesogenic society should be seen as a public health concern. |
| PubMedID- 21324239 | The average annual incidence of diabetes in patients with schizophrenia was 1.84% from 2000 to 2005. |
| PubMedID- 20923921 | (2006) trialled a skills training intervention aimed at older schizophrenia patients with diabetes which achieved a significant reduction in weight gain at 6 months. |
| PubMedID- 23775046 | Background: the prevalence of diabetes in patients with schizophrenia is 2- to 3-fold higher than in the general population. |
| PubMedID- 25878665 | Epidemiological studies show an increased risk of developing diabetes in people with schizophrenia with and without antipsychotics . |
| PubMedID- 22443212 | The current literature assessing the management of type ii diabetes for individuals with schizophrenia and schizoaffective disorders has indicated that there are a number of tactics used to manage blood glucose levels. |
| PubMedID- 21414605 | Methods: eleven known risk variants of type ii diabetes were genotyped in patients with schizophrenia in a sample of 410 danish patients, each matched with two healthy control subjects on sex, birth year, and month. |
| PubMedID- 23369226 | diabetes mellitus in patients with schizophrenia in west-bank, palestine. |
| PubMedID- 21937796 | Results: impairment of processing speed, attention/working memory, executive functioning and visual memory in schizophrenia patients with diabetes was significantly poorer than that of the schizophrenia patients (all p<0.05). |
| PubMedID- 25722989 | Both these hormones play an important role in the onset of diabetes in patients with schizophrenia . |
| PubMedID- 22472311 | Indeed, there is evidence that there is a metabolic predisposition to diabetes in patients with schizophrenia that is exacerbated by obesity and thereby contributes to cardiovascular disease and other co-morbid illnesses. |
| PubMedID- 20978096 | Risk of acute complications of diabetes among people with schizophrenia in ontario, canada. |
| PubMedID- 20304611 | Conclusion: when treating schizophrenia patients with preexisting diabetes, psychiatrists need to monitor the occurrence of diabetes regularly regardless of antipsychotic class, strike a balance, and provide the most efficacious antipsychotic medication. |
| PubMedID- 25937183 | Conclusions: there is no evidence that type 2 diabetes patients with schizophrenia have worse diabetes control than those without a severe mental illness in general practices. |
| PubMedID- 20434886 | A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. |
| PubMedID- 21424900 | Predictors of quality of life in type 2 diabetes patients with schizophrenia, major mood disorder, and without mental illness. |
| PubMedID- 20939648 | A 75-g oral glucose tolerance test (ogtt) was performed in 22 mildly obese, diabetes-free, japanese patients with schizophrenia who received risperidone or olanzapine for at least 2 months. |
| PubMedID- 26555485 | In schizophrenia with diabetes, males had significantly worse cognition than females in all cognitive domains. |
| PubMedID- 23941126 | Methods: schizophrenia patients without (pre-)diabetes (n = 86) were compared with pre-diabetic (n = 10) and diabetic patients (n = 10). |
| PubMedID- 20467177 | The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone. |
| PubMedID- 21265491 | Untreated hypertension, untreated dyslipidemia and untreated diabetes are strongly associated with schizophrenia (3.79 ), (3.79 ), (6.38 ), respectively. |
| PubMedID- 23439746 | Since the introduction of atypical antipsychotics nearly 20 years ago, there has been a 0.7% per year higher rate of diabetes type ii in patients with schizophrenia compared the general population. |
| PubMedID- 26469976 | Nasrallah et al reported a high proportion of under-diagnosis and under-treatment of hypertension, dyslipidemia and diabetes in schizophrenia . |
| PubMedID- 25832526 | Methods: relevant studies on schizophrenia with type 2 diabetes mellitus in china were searched through pubmed, medline, cbm, cnki and vip from 1997 to 2014. |
Page: 1